EducationalSymposia
Description
Room: Grace
BENEFITS AND LIMITATIONS UNDERLYING THE PROGRESS IN THE UTILIZATION OF REAL-WORLD DATA IN JAPAN
The past decade has seen tremendous progress in the use of real-world data (RWD) by outcomes researchers for various purposes in Japan. With this, Japan-specific and non-specific limitations in the use and interpretation of RWD have become evident. In this symposium, leading experts will provide viewpoints on the benefit and limitations of RWD.

Moderator: Ataru Igarashi, PhD
Associate Professor, Department of Drug Policy and Management, University of Tokyo, Tokyo, Japan

Speaker: Hideo Yasunaga, MD, PhD
Professor, Department of Clinical Epidemiology and Health Economics, University of Tokyo, Tokyo, Japan

Speaker: Elizabeth T Masters, MS, MPH
Director, Outcomes & Evidence, Pfizer Inc., New York, NY, USA

(Sponsored by Pfizer Japan Inc.)
Tags